These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 18667634)
1. Gender-dependent HLA-DR-restricted epitopes identified from herpes simplex virus type 1 glycoprotein D. Zhang X; Castelli FA; Zhu X; Wu M; Maillère B; BenMohamed L Clin Vaccine Immunol; 2008 Sep; 15(9):1436-49. PubMed ID: 18667634 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic immunization with a mixture of herpes simplex virus 1 glycoprotein D-derived “asymptomatic” human CD8+ T-cell epitopes decreases spontaneous ocular shedding in latently infected HLA transgenic rabbits: association with low frequency of local PD-1+ TIM-3+ CD8+ exhausted T cells. Khan AA; Srivastava R; Chentoufi AA; Geertsema R; Thai NT; Dasgupta G; Osorio N; Kalantari M; Nesburn AB; Wechsler SL; BenMohamed L J Virol; 2015 Jul; 89(13):6619-32. PubMed ID: 25878105 [TBL] [Abstract][Full Text] [Related]
3. A novel HLA (HLA-A*0201) transgenic rabbit model for preclinical evaluation of human CD8+ T cell epitope-based vaccines against ocular herpes. Chentoufi AA; Dasgupta G; Christensen ND; Hu J; Choudhury ZS; Azeem A; Jester JV; Nesburn AB; Wechsler SL; BenMohamed L J Immunol; 2010 Mar; 184(5):2561-71. PubMed ID: 20124097 [TBL] [Abstract][Full Text] [Related]
4. Immunodominant epitopes in herpes simplex virus type 2 glycoprotein D are recognized by CD4 lymphocytes from both HSV-1 and HSV-2 seropositive subjects. Kim M; Taylor J; Sidney J; Mikloska Z; Bodsworth N; Lagios K; Dunckley H; Byth-Wilson K; Denis M; Finlayson R; Khanna R; Sette A; Cunningham AL J Immunol; 2008 Nov; 181(9):6604-15. PubMed ID: 18941251 [TBL] [Abstract][Full Text] [Related]
15. Phenotypic and functional characterization of herpes simplex virus glycoprotein B epitope-specific effector and memory CD8+ T cells from symptomatic and asymptomatic individuals with ocular herpes. Khan AA; Srivastava R; Spencer D; Garg S; Fremgen D; Vahed H; Lopes PP; Pham TT; Hewett C; Kuang J; Ong N; Huang L; Scarfone VM; Nesburn AB; Wechsler SL; BenMohamed L J Virol; 2015 Apr; 89(7):3776-92. PubMed ID: 25609800 [TBL] [Abstract][Full Text] [Related]
16. A Herpes Simplex Virus Type 1 Human Asymptomatic CD8+ T-Cell Epitopes-Based Vaccine Protects Against Ocular Herpes in a "Humanized" HLA Transgenic Rabbit Model. Srivastava R; Khan AA; Huang J; Nesburn AB; Wechsler SL; BenMohamed L Invest Ophthalmol Vis Sci; 2015 Jun; 56(6):4013-28. PubMed ID: 26098469 [TBL] [Abstract][Full Text] [Related]
17. Prophylactic herpes simplex virus type 2 vaccine adjuvanted with a universal CD4 T cell helper peptide induces long-term protective immunity against lethal challenge in mice. Li X; Zhang S; Lei J; Zhu Y; Zhou X; Xiao J; Xiang T Int Immunopharmacol; 2018 Aug; 61():100-108. PubMed ID: 29857239 [TBL] [Abstract][Full Text] [Related]
18. Herpes simplex virus type 1 glycoproteins gB, gC and gD are major targets for CD4 T-lymphocyte cytotoxicity in HLA-DR expressing human epidermal keratinocytes. Mikloska Z; Cunningham AL J Gen Virol; 1998 Feb; 79 ( Pt 2)():353-61. PubMed ID: 9472620 [TBL] [Abstract][Full Text] [Related]
19. Design and evaluation of a multi-epitope assembly peptide (MEAP) against herpes simplex virus type 2 infection in BALB/c mice. Wang X; Xie G; Liao J; Yin D; Guan W; Pan M; Li J; Li Y Virol J; 2011 May; 8():232. PubMed ID: 21575169 [TBL] [Abstract][Full Text] [Related]
20. Intramuscular Immunization of Mice with the Live-Attenuated Herpes Simplex Virus 1 Vaccine Strain VC2 Expressing Equine Herpesvirus 1 (EHV-1) Glycoprotein D Generates Anti-EHV-1 Immune Responses in Mice. Liu SA; Stanfield BA; Chouljenko VN; Naidu S; Langohr I; Del Piero F; Ferracone J; Roy AA; Kousoulas KG J Virol; 2017 Jun; 91(12):. PubMed ID: 28404844 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]